The Cutting Edge: Gene Editing/CRISPR

February 27 / 12:30 PM - 2:00 PM EST
02/27/20 12:30 PM 02/27/20 2:00 PM America/New_York The Cutting Edge: Gene Editing/CRISPR Advanced Technology Research Facility, 8560 Progress Drive, Frederick, US
Event Location: 
Advanced Technology Research Facility
8560 Progress Drive
Frederick, MD 21702
United States

The topic for this installment of the Biotech Connector Speaker Series is "The Cutting Edge: Gene Editing/CRISPR." The speakers will be Dr. Raj Chari of the Frederick National Laboratory and Dr. Gregory Alberts of Lonaza Pharma Bioscience Solutions.

Dr. Raj Chari
Director, Genome Modification Core Laboratory
Frederick National Lab for Cancer Research
Dr. Raj Chari obtained his bachelor’s degrees in both biochemistry and computer science at the University of British Columbia. He then went onto doing his PhD under the supervision of Dr. Wan Lam at the British Columbia Cancer Research Centre, specializing in lung cancer genomics. Subsequently, he did his postdoctoral fellowship at Harvard Medical School with Dr. George Church where he helped develop genome engineering technologies. After briefly working in industry at AbVitro and Juno Therapeutics, he is now the director of the Genome Modification Core at the Frederick National Lab for Cancer Research.

Dr. Gregory Alberts
Global Subject Matter Expert Transfection and Genome Editing
Lonza Pharma Bioscience Solutions
Dr. Gregory Alberts is currently the Global Subject Matter Expert for Lonza, and has worked at Lonza (and previously Amaxa) since 2003. He was the first field scientist hired by Amaxa in North America, and he has considerable experience in Nucleofection, primary cells (including stem cells and iPSC generation), and is well versed in the use of CRISPR and other genome-editing technologies with Nucleofection. He received a Ph.D. from George Washington University in 2003 in Molecular Biology, and an M.S. in Bacterial Genetics from the University of Illinois-Chicago in 1986.